Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Karlo M Lopez

California State University-Bakersfield, USA

Title: Lysyl oxidase: A versatile and elusive enzyme

Biography

Biography: Karlo M Lopez

Abstract

Lysyl oxidase is an extracellular matrix, copper-dependent, amine oxidase that catalyzes a key crosslinking step in collagen and
elastin. Th e enzyme is synthesized as a proenzyme that, upon excretion to the extracellular matrix, is cleaved at the Gly168-
Asp169 bond by procollagen C-proteinase in the mammalian form of the enzyme. Lysyl oxidase is highly regulated and changes in its
regulation have been shown to play a role in fi brosis and several other diseases. More recently, the enzyme has been shown to play a
paradoxical role in cancer. In the early stages of cancer, the cleaved pro-peptide has been shown to inhibit the RAS oncogene, whereas
in late stages of cancer lysyl oxidase has been shown to promote metastasis. Lysyl oxidase is highly insoluble and this has hampered
its full characterization. Recent work in the by our study group has addressed some of the issues associated with the insolubility and
characterization of the enzyme. In particular, this talk will address how plasmids were used to increase enzyme yields over those
obtained directly from bovine aortic tissue, the role solubility tags play on enzyme activity and suitability for characterization studies,
and will end with an innovative new approach to drug delivery that targets lysyl oxidase in cancer cells but remains inactive in normal
cells.